• DOI:10.4088/JCP.V65N0403
Corpus ID: 32752143

Neuroleptic malignant syndrome and atypical antipsychotic drugs.

@article{Ananth2004NeurolepticMS,
  title={Neuroleptic malignant syndrome and atypical antipsychotic drugs.},
  author={J. Ananth and S. Parameswaran and S. Gunatilake and K. Burgoyne and Taghrid Sidhom},
  journal={The Journal of clinical psychiatry},
  year={2004},
  volume={65 4},
  pages={
          464-70
        }
}

• J. Ananth, S. Parameswaran, +2 authors Taghrid Sidhom
• Published 2004
• Medicine
• The Journal of clinical psychiatry

OBJECTIVE The incidence of neuroleptic malignant syndrome (NMS) is not known, but the frequency of its occurrence with conventional antipsychotic agents has been reported to vary from 0.02% to 2.44%. DATA SOURCES MEDLINE search conducted in January 2003 and review of references within the retrieved articles. DATA SYNTHESIS Our MEDLINE research yielded 68 cases (21 females and 47 males) of NMS associated with atypical antipsychotic drugs (clozapine, N = 21; risperidone, N = 23; olanzapine, N… Expand

View on PubMed

psychiatry.utoronto.ca

Save to Library

Create Alert

Cite

Launch Research Feed